As of 2026-08-18, the Relative Valuation of Ionis Pharmaceuticals Inc (IONS) is (84.51) USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.63 USD, the upside of Ionis Pharmaceuticals Inc based on Relative Valuation is -244.1%.
The range of the Relative Valuation is (86.04) - (96.93) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.1x - 28.5x | 22.8x |
| Forward P/E multiples | 25.3x - 28.5x | 26.9x |
| Fair Price | (86.04) - (96.93) | (84.51) |
| Upside | -246.8% - -265.3% | -244.1% |
| Date | P/E |
| 2026-08-14 | -16.83 |
| 2026-08-13 | -16.43 |
| 2026-08-12 | -16.62 |
| 2026-08-11 | -16.30 |
| 2026-08-10 | -16.74 |
| 2026-08-07 | -16.63 |
| 2026-08-06 | -16.02 |
| 2026-08-05 | -15.93 |
| 2026-08-04 | -16.19 |
| 2026-08-03 | -16.02 |
| 2026-07-31 | -15.22 |
| 2026-07-30 | -15.67 |
| 2026-07-29 | -15.89 |
| 2026-07-28 | -16.26 |
| 2026-07-27 | -16.45 |
| 2026-07-24 | -16.63 |
| 2026-07-23 | -16.43 |
| 2026-07-22 | -15.88 |
| 2026-07-21 | -15.70 |
| 2026-07-20 | -15.57 |
| 2026-07-17 | -15.99 |
| 2026-07-16 | -16.07 |
| 2026-07-15 | -16.09 |
| 2026-07-14 | -16.15 |
| 2026-07-13 | -16.69 |
| 2026-07-10 | -17.13 |
| 2026-07-09 | -18.90 |
| 2026-07-08 | -24.83 |
| 2026-07-07 | -25.38 |
| 2026-07-06 | -24.46 |
| 2026-07-02 | -24.05 |
| 2026-07-01 | -23.28 |
| 2026-06-30 | -23.31 |
| 2026-06-29 | -23.73 |
| 2026-06-26 | -23.87 |
| 2026-06-25 | -23.03 |
| 2026-06-24 | -22.50 |
| 2026-06-23 | -22.34 |
| 2026-06-22 | -22.31 |
| 2026-06-18 | -21.79 |
| 2026-06-17 | -21.85 |
| 2026-06-16 | -21.49 |
| 2026-06-15 | -21.75 |
| 2026-06-12 | -21.55 |
| 2026-06-11 | -21.71 |
| 2026-06-10 | -21.56 |
| 2026-06-09 | -21.93 |
| 2026-06-08 | -21.62 |
| 2026-06-05 | -21.90 |
| 2026-06-04 | -22.09 |